These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28418032)
1. A New Approach to Evaluating Aberrant DNA Methylation Profiles in Hepatocellular Carcinoma as Potential Biomarkers. Yang Y; Zhao L; Huang B; Hou G; Zhou B; Qian J; Yuan S; Xiao H; Li M; Zhou W Sci Rep; 2017 Apr; 7():46533. PubMed ID: 28418032 [TBL] [Abstract][Full Text] [Related]
2. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278 [TBL] [Abstract][Full Text] [Related]
3. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
4. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction. Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805 [TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma. Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368 [TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Li Z; Zhang H; Yang J; Hao T; Li S Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295 [TBL] [Abstract][Full Text] [Related]
7. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
9. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line. Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710 [TBL] [Abstract][Full Text] [Related]
10. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma. Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608 [TBL] [Abstract][Full Text] [Related]
11. DNMT1 mediated promoter methylation of GNAO1 in hepatoma carcinoma cells. Xu D; Du M; Zhang J; Xiong P; Li W; Zhang H; Xiong W; Liu F; Liu J Gene; 2018 Jul; 665():67-73. PubMed ID: 29709639 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array. Shin SH; Kim BH; Jang JJ; Suh KS; Kang GH J Korean Med Sci; 2010 Aug; 25(8):1152-9. PubMed ID: 20676325 [TBL] [Abstract][Full Text] [Related]
13. Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis. Yu J; Zhang HY; Ma ZZ; Lu W; Wang YF; Zhu JD Cell Res; 2003 Oct; 13(5):319-33. PubMed ID: 14672555 [TBL] [Abstract][Full Text] [Related]
14. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma. Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662 [TBL] [Abstract][Full Text] [Related]
15. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447 [TBL] [Abstract][Full Text] [Related]
16. Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma. Zhang T; Guan G; Chen T; Jin J; Zhang L; Yao M; Qi X; Zou J; Chen J; Lu F; Chen X Asia Pac J Clin Oncol; 2018 Oct; 14(5):e352-e358. PubMed ID: 29749051 [TBL] [Abstract][Full Text] [Related]
17. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3. Xu L; Dai W; Li J; He L; Wang F; Xia Y; Chen K; Li S; Liu T; Lu J; Zhou Y; Wang Y; Guo C Oncotarget; 2016 May; 7(18):26027-41. PubMed ID: 27029030 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma. Jung N; Won JK; Kim BH; Suh KS; Jang JJ; Kang GH J Korean Med Sci; 2012 Jun; 27(6):594-604. PubMed ID: 22690089 [TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180 [TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers. Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]